March 26, 2020 / 8:12 PM / 2 months ago

BRIEF-Celldex Therapeutics Q4 Loss Per Share $0.64

Celldex Therapeutics Inc:

* CELLDEX PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND YEAR END 2019 RESULTS

* Q4 REVENUE $900,000 VERSUS $9.5 MILLION

* CELLDEX THERAPEUTICS - BELIEVES CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AT DEC 31, 2019 SUFFICIENT TO FUND PLANNED OPERATIONS INTO Q1 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below